News for Relmada Therapeutics, Inc. (RLMD)

**media[534005]**

RLMD stock touches 52-week low at $0.35 amid market challenges

Relmada (RLMD) shares finished 5% higher after the company said it would no longer pursue Phase 3 studies for its drug REL-1017 and was exploring strategic options. Read more here.

Relmada Therapeutics has Commenced a Process to Explore Strategic Alternatives to Maximize Shareholder Value CORAL GABLES, Fla., Dec. 09, 2024 (GLOBE NEWSWI

Mizuho has downgraded Relmada Therapeutics (RLMD) to neutral on the apparent demise of its drug candidate REL-1017 for major depressive disorder. Read more here.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.30% to 44,838.93 while ...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 250 points on Wednesday. The Dow traded up 0.56% to 44,957.85 while the NASDAQ ...

Relmada shares plunge on Phase 3 trial failure

Conference being held November 19-21, 2024 CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. ( RLMD, ”œRelmada”, ”œthe Co

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2024 Earnings Call November 7, 2024 4:30 PM ETCompany ParticipantsTim McCarthy - Investor RelationsSergio...

Israel-based Galmed Pharmaceuticals Ltd. (GLMD), a biopharmaceutical company is up over 49 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Insider Activity Heats Up: Wednesday's Top Buys and Sells Revealed

California-based Tenon Medical, Inc. (TNON), a medical device company is up over 160 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

The rising demand for maternal mental health services is largely due to the increasing incidence of conditions like postpartum depression, dysthymia,...

California-based skincare development company Elevai Labs, Inc. (ELAB) is up over 94 percent in Thursday's pre-market trading. The following are some of the stocks making big moves in Thursday's pre-market trading.

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Relmada Therapeutics, Inc. (RLMD) is down over 30% in Friday's pre-market trading. Here is the list of the other big movers..

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.55%

GuruFocus Article or News written by insider and the topic is about: